Share-based Compensation (Tables)

12 Months Ended

Mar. 31, 2026

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Summary of share-based compensation expense

The following table summarizes the share-based compensation expense for grants included in the Consolidated Statements of Operations for fiscal 2026, 2025 and 2024:

	Year Ended March 31,
(In thousands)	2026		2025		2024
Product development	$	13,234	$	10,064	$	7,380
Sales and marketing		2,079		1,665		831
General and administrative		6,505		6,048		5,900
Total share-based compensation expense	$	21,818	$	17,777	$	14,111

Activity related SSARs award

The following table summarizes the activity during fiscal 2026 for SSARs awarded under our Equity Incentive Plans:

(In thousands, except share and per share data)	Number of Rights			Weighted- Average Exercise Price		Remaining Contractual Term		Aggregate Intrinsic Value
				(per right)		(in years)
Outstanding at April 1, 2025		394,959		$	20.04
Granted		—			—
Exercised		(78,976	)		20.12
Forfeited		—			—
Cancelled/expired		—			—
Outstanding at March 31, 2026		315,983		$	20.02		1.2	$	16,153
Exercisable at March 31, 2026		315,983		$	20.02		1.2	$	16,153
Vested at March 31, 2026		315,983		$	20.02		1.2	$	16,153

The following table presents additional information related to SSARs activity during fiscal 2026, 2025 and 2024:

(In thousands)	2026		2025		2024
Compensation expense	$	—	$	—	$	—
Total intrinsic value of SSARs exercised	$	6,631	$	65,080	$	16,889
Total fair value of SSARs vesting	$	—	$	—	$	—

Activity related to restricted shares awarded by the Company

The following table summarizes the activity during the twelve months ended March 31, 2026 for restricted shares awarded under our Equity Incentive Plans:

	Number of Shares			Weighted- Average Grant- Date Fair Value
				(per share)
Outstanding at April 1, 2025		229,710		$	76.01
Granted		4,970			100.19
Vested		(154,939	)		67.33
Forfeited		(4,949	)		92.79
Expected to vest at March 31, 2026		74,792		$	94.58

Restricted stock activity

The following table presents additional information related to restricted share activity during fiscal years 2026, 2025, and 2024:

(In thousands)	2026		2025		2024
Compensation expense	$	4,448	$	11,379	$	11,146
Total fair value of restricted share vesting	$	9,831	$	13,182	$	6,595

Employee Stock [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Schedule of principal assumptions utilized in valuing service condition SARs

We used the following inputs including principal assumptions for the following offering period reflected in our consolidated financial statements:

	Offering Period Ending			Offering Period Ended			Offering Period Ended			Offering Period Ended			Offering Period Ended
	June 30, 2026			December 31, 2025			June 30, 2025			December 31, 2024			June 30, 2024
Grant date fair value	$	118.84		$	115.19		$	131.71		$	103.43		$	81.60
Risk-free interest rate over contractual term		3.62	%		4.30	%		4.31	%		4.91	%		5.36	%
Expected term (in years)		0.49			0.50			0.49			0.50			0.41
Expected volatility		45.17	%		60.10	%		42.40	%		40.93	%		47.41	%

Restricted Stock Units (RSUs) [Member]

Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]

Activity related to restricted shares awarded by the Company

The following table summarizes the activity during the twelve months ended March 31, 2026 for restricted stock units awarded under our Equity Incentive Plans:

	Number of Shares			Weighted- Average Grant- Date Fair Value
				(per share)
Outstanding at April 1, 2025		181,195		$	118.90
Granted		209,080			126.05
Vested		(88,424	)		101.56
Forfeited		(10,896	)		130.75
Expected to vest at March 31, 2026		290,955		$	128.87

Restricted stock activity

The following table presents additional information related to restricted stock unit activity during fiscal 2026:

(In thousands)	2026		2025		2024
Compensation expense	$	16,368	$	5,591	$	2,321
Total fair value of restricted stock unit vesting	$	8,980	$	932	$	900